Contract awardedBlood products and plasma-derived medicines

CSL Behring supplies Beriplex to The Christie NHS Foundation Trust

The Christie NHS Foundation Trust ordered Beriplex from CSL Behring. Beriplex is a prothrombin complex concentrate, a medicine made from blood plasma, and the order was for supply only.

The trust placed the order through a dynamic purchasing system in June 2026. It was worth £12,000 and covered one month, due to end in July 2026.

What
Blood products and plasma-derived medicines
Supplier
CSL Behring
Value
£12,000
How it was bought
Call-off from a dynamic purchasing system
Dates and next
Jun 2026 to Jul 2026

How it was bought

1 official notice
  1. 11 Jun 2026Bids closed
  2. 12 Jun 2026Contract starts
  3. 12 Jul 2026Contract ends
  4. 15 Jul 2026Award noticeContracts Finder

How it compares

With every blood products and plasma-derived medicines award since 2021

Half of awards fall between £88,725 and £600,000Median £400,000

Awards
37
Firms that won them
14
Median award
£400,000
of 33 with a value
This award
Smaller than 100%
of them
Typical length
2 years
In North West
2 awards

CSL Behring ranks 3rd of 14 firms for blood products and plasma-derived medicines awards since 2021.

RankFirmAwardsValue
1Locked15£8.39m
2Locked9£602m
3Locked7£621,413
3CSL Behring Won this one7£483,408
5Locked4£111,200
6Locked1£1.62m
See who wins this work

Figures to 21 November 2026

Blood products and plasma-derived medicines at other buyers

The Christie NHS Foundation Trust has awarded 344 contracts since 2021.

See The Christie NHS Foundation Trust's page
  • CSL Behring has won 8 public contracts since 2021.